Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedRecruitment status on the study page was updated to No longer looking for participants, signaling that enrollment has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was reformatted, with the revision tag updated to v3.6.0.SummaryDifference0.4%

- Check11 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version. The update reflects a metadata/version change rather than changes to study content or eligibility details.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows revision v3.5.4, replacing the previous v3.5.3, indicating a frontend update.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version updates from **v3.5.2** to **v3.5.3** without changing study details.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.